Pre-made Lampalizumab benchmark antibody ( Fab, anti-CFD therapeutic antibody, Anti-ADIPSIN/ADN/DF/PFD Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-293

Pre-Made Lampalizumab biosimilar, Fab, Anti-CFD Antibody: Anti-ADIPSIN/ADN/DF/PFD therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Lampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody that binds to complement factor D; it was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-293-1mg 1mg 3090
GMP-Bios-ab-293-10mg 10mg Inquiry
GMP-Bios-ab-293-100mg 100mg Inquiry
GMP-Bios-ab-293-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Lampalizumab biosimilar, Fab, Anti-CFD Antibody: Anti-ADIPSIN/ADN/DF/PFD therapeutic antibody
INN Name Lampalizumab
TargetCFD
FormatFab
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusDiscontinued
100% SI Structure4d9q:HL:ED/4d9r:HL:ED
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2012
Year Recommended2013
CompaniesTanox;Genentech
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedDry age-related macular degeneration
Development Techna